Illumina News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

05.08.21	Illumina Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
05.08.21	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021 (PR Newswire)
04.08.21	Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India (PR Newswire)
03.08.21	Ausblick: Illumina informiert über die jüngsten Quartalsergebnisse (finanzen.net)
21.07.21	Erste Schätzungen: Illumina stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
01.06.21	Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis (Businesswire)
27.05.21	Illumina To Webcast Upcoming Investor Conference (Businesswire)
17.05.21	Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development (Businesswire)
30.04.21	Illumina-Aktie: Das sind die Analysten-Einstufungen des vergangenen Monats (finanzen.net)
29.04.21	Illumina To Webcast Upcoming Investor Conference (Businesswire)
29.04.21	Illumina Files Action For Annulment Of EC's Decision Asserting Jurisdiction To Review GRAIL Deal (RTTNews)
29.04.21	Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition (Businesswire)
28.04.21	Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative (Businesswire)
27.04.21	Illumina Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
27.04.21	Illumina Reports Financial Results for First Quarter of Fiscal Year 2021 (Businesswire)
25.04.21	Ausblick: Illumina zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
22.04.21	Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic (Businesswire)
20.04.21	Llumina Remains Committed To GRAIL Deal - Quick Facts (RTTNews)
20.04.21	Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test (Businesswire)
14.04.21	Illumina, Inc. -- Moody's announces completion of a periodic review of ratings of Illumina, Inc. (Moodys)
12.04.21	Erste Schätzungen: Illumina gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
05.04.21	Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021 (Businesswire)
31.03.21	Experten sehen bei Illumina-Aktie Potenzial (finanzen.net)
31.03.21	FTC Seeks To Block Illumina's Proposed $7.1 Bln Acquisition Of Grail (RTTNews)
30.03.21	Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test (Businesswire)
18.03.21	Illumina Announces Board Changes (Businesswire)
16.03.21	Illumina, Inc. -- Moody's assigns Baa3 rating to Illumina's notes offering (Moodys)
11.03.21	Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women (Businesswire)
10.03.21	Illumina, Inc. -- Moody's assigns a first-time Baa3 issuer rating to Illumina; outlook stable (Moodys)
09.03.21	Illumina, Inc. -- Moody's assigns a first-time Baa3 rating to Illumina; outlook stable (Moodys)
09.03.21	Illumina, Inc. -- Moody's assigns a first-time Baa3 rating to Illumina; outlook stable (Moodys)
05.03.21	Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia (Businesswire)
28.02.21	Februar 2021: Experten empfehlen Illumina-Aktie mehrheitlich zum Kauf (finanzen.net)
19.02.21	Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases (Businesswire)
10.02.21	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
08.02.21	Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle (Businesswire)
04.02.21	Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium (Businesswire)
01.02.21	Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China (Businesswire)
27.01.21	Erste Schätzungen: Illumina legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
25.01.21	Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021 (Businesswire)
20.01.21	Illumina Wins Patent Infringement Suit against BGI in the UK (Businesswire)
11.01.21	New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale (Businesswire)
11.01.21	Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling (Businesswire)
06.01.21	Illumina, Helix Collaborate To Assess Prevalence Of New SARS-CoV-2 UK Variant In U.S. (RTTNews)
06.01.21	Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure (Businesswire)
31.12.20	Dezember 2020: So schätzen Experten die Illumina-Aktie ein (finanzen.net)
22.12.20	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
08.12.20	Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing (Businesswire)
18.11.20	Illumina to Webcast Upcoming Investor Conference Presentation (Businesswire)
12.11.20	Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

16.12.24		Handel in New York: NASDAQ 100 zeigt sich zum Start des Montagshandels fester
13.12.24		Gewinne in New York: NASDAQ 100 mittags mit grünem Vorzeichen
11.12.24		Aufschläge in New York: NASDAQ 100 am Mittwochmittag im Plus
11.12.24		Gute Stimmung in New York: NASDAQ 100 klettert zum Handelsstart
20.11.24		Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone
20.11.24		Schwacher Handel: NASDAQ 100 schwächelt mittags
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer

16.12.24

Handel in New York: NASDAQ 100 zeigt sich zum Start des Montagshandels fester

13.12.24

Gewinne in New York: NASDAQ 100 mittags mit grünem Vorzeichen

11.12.24

Aufschläge in New York: NASDAQ 100 am Mittwochmittag im Plus

11.12.24

Gute Stimmung in New York: NASDAQ 100 klettert zum Handelsstart

20.11.24

Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone